Abstract
A clot lysis method for estimating serum antiplasmin activity is described using streptokinase-activated serum euglobulin as a source of plasmin, and human plasma euglobulin as a source of fibrinogen. Epsilon-amino-caproic acid is used to prevent residual activator activity in the clot.
Keywords